Cochrane review: Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma

BACKGROUND In acute asthma inhaled beta2-agonists are often administered to relieve bronchospasm by wet nebulisation, but some have argued that metered-dose inhalers with a holding chamber (spacer) can be equally effective. Nebulisers require a power source and need regular maintenance, and are more expensive in the community setting. OBJECTIVES To assess the effects of holding chambers (spacers) compared to nebulisers for the delivery of beta2-agonists for acute asthma. SEARCH STRATEGY We last searched the Cochrane Airways Group trials register in January 2006 and the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 4, 2005). SELECTION CRITERIA Randomised trials in adults and children (from two years of age) with asthma, where spacer beta2-agonist delivery was compared with wet nebulisation. DATA COLLECTION AND ANALYSIS Two reviewers independently applied study inclusion criteria (one reviewer for the first version of the review), extracted the data and assessed trial quality. Missing data were obtained from the authors or estimated. Results are reported with 95% confidence intervals (CI). MAIN RESULTS This review has been updated in January 2006 and four new trials have been added. 2066 children and 614 adults are now included in 25 trials from emergency room and community settings. In addition, six trials on in-patients with acute asthma (213 children and 28 adults) have been reviewed. Method of delivery of beta2-agonist did not appear to affect hospital admission rates. In adults, the relative risk of admission for spacer versus nebuliser was 0.97 (95% CI 0.63 to 1.49). The relative risk for children was 0.65 (95% CI: 0.4 to 1.06). In children, length of stay in the emergency department was significantly shorter when the spacer was used, with a mean difference of -0.47 hours (95% CI: -0.58 to -0.37). Length of stay in the emergency department for adults was similar for the two delivery methods. Peak flow and forced expiratory volume were also similar for the two delivery methods. Pulse rate was lower for spacer in children, mean difference -7.6% baseline (95% CI: -9.9 to -5.3% baseline). AUTHORS' CONCLUSIONS Metered-dose inhalers with spacer produced outcomes that were at least equivalent to nebuliser delivery. Spacers may have some advantages compared to nebulisers for children with acute asthma.

[1]  S. Sritippayawan,et al.  Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler‐spacer vs. jet nebulizer in young children with wheezing , 2005, Pediatric pulmonology.

[2]  A. Bundgaard,et al.  Cumulative dose-response study comparing terbutaline pressurized aerosol administered via a pearshaped spacer and terbutaline in a nebulized solution , 2004, European Journal of Clinical Pharmacology.

[3]  S. Johnson,et al.  Pulmonary artery aneurysm and tuberous sclerosis , 2003, Thorax.

[4]  P. Camargos,et al.  Efficacy and safety of a home‐made non‐valved spacer for bronchodilator therapy in acute asthma , 2002, Acta paediatrica.

[5]  C. Hamilton,et al.  A comparison of albuterol administered by metered-dose inhaler and spacer with albuterol by nebulizer in adults presenting to an urban emergency department with acute asthma. , 2002, Chest.

[6]  G. Dutau,et al.  Fortes doses de salbutamol par aérosol doseur et chambre d’inhalation chez les nourrissons et les jeunes enfants siffleurs , 2001 .

[7]  C. Robertson,et al.  Successful implementation of spacer treatment guideline for acute asthma , 2001, Archives of disease in childhood.

[8]  D. Floret,et al.  High-Dose Albuterol by Metered-Dose Inhaler Plus a Spacer Device Versus Nebulization in Preschool Children With Recurrent Wheezing: A Double-Blind, Randomized Equivalence Trial , 2000, Pediatrics.

[9]  E. Gilad,et al.  Is nebulized aerosol treatment necessary in the pediatric emergency department? , 2000, Chest.

[10]  J. Castro‐Rodriguez,et al.  Randomized trial of salbutamol via metered‐dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age , 2000, Pediatric pulmonology.

[11]  M. Asher,et al.  Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma. , 2000, The Journal of pediatrics.

[12]  J. Wildhaber,et al.  Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. , 1999, The Journal of pediatrics.

[13]  J. Cogswell,et al.  A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital , 1999, Archives of disease in childhood.

[14]  M. Chávez,et al.  Salbutamol inhalado o nebulizado en el tratamiento de la exacerbación aguda del asma en el preescolar. Estudio comparativo aleatorizado. , 1999 .

[15]  C. Rodrigo,et al.  Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer. , 1998, The American journal of emergency medicine.

[16]  C. Robertson,et al.  Treatment of acute asthma: Salbutamol via jet nebuliser vs spacer and metered dose inhaler , 1998, Journal of paediatrics and child health.

[17]  B. Lipworth,et al.  Effects of airway calibre on lung delivery of nebulised salbutamol. , 1997, Thorax.

[18]  N. Noviski,et al.  Nebulized wet aerosol treatment in emergency department--is it essential? Comparison with large spacer device for metered-dose inhaler. , 1997, Chest.

[19]  J. M. FitzGerald,et al.  Bronchodilator delivery in acute airflow obstruction. A meta-analysis. , 1997, Archives of internal medicine.

[20]  N. Molfino,et al.  Treatment of acute severe asthma with inhaled albuterol delivered via jet nebulizer, metered dose inhaler with spacer, or dry powder. , 1997, Chest.

[21]  V. Batra,et al.  Comparative efficacy of jet nebulizer and metered dose inhaler with spacer device in the treatment of acute asthma. , 1997, Indian pediatrics.

[22]  B. Navarro,et al.  Comparación entre salbutamol administrado por inhaladores de dosis medida con espaciador vs nebulizado en niños con asma aguda , 1997 .

[23]  J. Bothner,et al.  Delivery of albuterol in a pediatric emergency department , 1996, Pediatric emergency care.

[24]  C. Rodrigo,et al.  Metered dose inhaler salbutamol treatment of asthma in the ED: comparison of two doses with plasma levels. , 1996, The American journal of emergency medicine.

[25]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[26]  M. Levitt,et al.  Comparative trial of continuous nebulization versus metered-dose inhaler in the treatment of acute bronchospasm. , 1995, Annals of emergency medicine.

[27]  K. Hsieh,et al.  Metered dose inhaler and nebuliser in acute asthma. , 1995, Archives of disease in childhood.

[28]  C. Macarthur,et al.  Randomised trial spacer v nebuliser for acute asthma. , 1995, Archives of Disease in Childhood.

[29]  S. Cunningham,et al.  Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. , 1995, Archives of pediatrics & adolescent medicine.

[30]  J. Mao,et al.  An open, prospective comparison of beta 2 agonists given via nebuliser, Nebuhaler, or pressurised inhaler by ambulance crew as emergency treatment. , 1995, Thorax.

[31]  C. Rodrigo,et al.  Comparison of salbutamol delivered by nebulizer or metered-dose inhaler with a pear-shaped spacer in acute asthma , 1993 .

[32]  M. Afilalo,et al.  A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. , 1993, Chest.

[33]  H. O'brodovich,et al.  Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. , 1993, The Journal of pediatrics.

[34]  A. Idris,et al.  Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. , 1993, Chest.

[35]  M. CoreraSánchez,et al.  Comparison of treatment of acute asthma attacks in children with salbutamol dispensed by the Volumatic dispenser or by a nebulizer , 1992 .

[36]  L. Hendeles,et al.  Relative amount of albuterol delivered to lung receptors from a metered-dose inhaler and nebulizer solution. Bioassay by histamine bronchoprovocation. , 1992, Chest.

[37]  G. Maguire,et al.  Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease. , 1991, Chest.

[38]  N. Morrone,et al.  [Bronchodilation induced by fenoterol in asthmatic patients: comparison of jet nebulization and spacer device]. , 1990, Revista paulista de medicina.

[39]  I. Masters,et al.  Single breath versus panting technique in salbutamol delivery through a 750 mL spacing device , 1990, Pediatric pulmonology.

[40]  P. P. Asperen,et al.  Comparative efficacy of terbutaline administered by Nebuhaler and by nebulizer in young children with acute asthma , 1989, The Medical journal of Australia.

[41]  G. Salzman,et al.  Aerosolized metaproterenol in the treatment of asthmatics with severe airflow obstruction. Comparison of two delivery methods. , 1989, Chest.

[42]  H. Levison,et al.  High-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. , 1989, Pediatrics.

[43]  R. Elston,et al.  Aerosol bronchodilator delivery methods. Relative impact on pulmonary function and cost of respiratory care. , 1989, Archives of internal medicine.

[44]  S. Spier,et al.  Wet nebulizer versus spacer and metered dose inhaler via tidal breathing. , 1989, The Journal of asthma : official journal of the Association for the Care of Asthma.

[45]  T. Morley,et al.  Comparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler with InspirEase in hospitalized asthmatic patients. , 1988, Chest.

[46]  A. Gelb,et al.  Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction. , 1988, Chest.

[47]  Z. Mohsenifar,et al.  Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients. , 1987, Chest.

[48]  Beasley Cr,et al.  Pear shaped spacer nebuhaler compared with nebulised solution for terbutaline administration in acute severe asthma. , 1985 .

[49]  L. A. Cupples,et al.  Comparison of metered-dose inhaler attached to an Aerochamber with an updraft nebulizer for the administration of metaproterenol in hospitalized patients. , 1985, The Journal of asthma : official journal of the Association for the Care of Asthma.

[50]  A. Millar,et al.  Improvement of pressurised aerosol deposition with Nebuhaler spacer device. , 1984, Thorax.

[51]  P. V. van Asperen,et al.  Nebuhaler versus nebuliser in children with acute asthma. , 1984, British medical journal.

[52]  M. H. Williams,et al.  Effect of bronchodilator therapy administered by canister versus jet nebulizer. , 1984, The Journal of allergy and clinical immunology.

[53]  M. Morgan,et al.  Terbutaline aerosol given through pear spacer in acute severe asthma. , 1982, British medical journal.

[54]  J. Paterson,et al.  Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma. , 1980, British Journal of Clinical Pharmacology.